HCPCS Service Codes - Other medical items or services

HCPCS Codes for Other medical items or services

• L3161

  Foot, adductus positioning device, adjustable

• L8721

  Receptor sole for use with l8720, replacement, each

• P9012

  Cryoprecipitate, each unit

• P9017

  Fresh frozen plasma (single donor), frozen within 8 hours of collection, each unit

• P9019

  Platelets, each unit

• P9020

  Platelet rich plasma, each unit

• P9023

  Plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit

• P9025

  Plasma, cryoprecipitate reduced, pathogen reduced, each unit

• P9026

  Cryoprecipitated fibrinogen complex, pathogen reduced, each unit

• P9027

  Red blood cells, leukocytes reduced, oxygen/ carbon dioxide reduced, each unit

• P9031

  Platelets, leukocytes reduced, each unit

• P9032

  Platelets, irradiated, each unit

• P9033

  Platelets, leukocytes reduced, irradiated, each unit

• P9034

  Platelets, pheresis, each unit

• P9035

  Platelets, pheresis, leukocytes reduced, each unit

• P9036

  Platelets, pheresis, irradiated, each unit

• P9037

  Platelets, pheresis, leukocytes reduced, irradiated, each unit

• P9041

  Infusion, albumin (human), 5%, 50 ml

• P9043

  Infusion, plasma protein fraction (human), 5%, 50 ml

• P9044

  Plasma, cryoprecipitate reduced, each unit

• P9045

  Infusion, albumin (human), 5%, 250 ml

• P9046

  Infusion, albumin (human), 25%, 20 ml

• P9047

  Infusion, albumin (human), 25%, 50 ml

• P9048

  Infusion, plasma protein fraction (human), 5%, 250 ml

• P9050

  Granulocytes, pheresis, each unit

• P9052

  Platelets, hla-matched leukocytes reduced, apheresis/pheresis, each unit

• P9053

  Platelets, pheresis, leukocytes reduced, cmv-negative, irradiated, each unit

• P9055

  Platelets, leukocytes reduced, cmv-negative, apheresis/pheresis, each unit

• P9059

  Fresh frozen plasma between 8-24 hours of collection, each unit

• P9060

  Fresh frozen plasma, donor retested, each unit

• P9070

  Plasma, pooled multiple donor, pathogen reduced, frozen, each unit

• P9071

  Plasma (single donor), pathogen reduced, frozen, each unit

• P9072

  Platelets, pheresis, pathogen reduced or rapid bacterial tested, each unit

• P9073

  Platelets, pheresis, pathogen-reduced, each unit

• Q0510

  Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant

• Q0511

  Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period

• Q0512

  Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period

• Q0513

  Pharmacy dispensing fee for inhalation drug(s); per 30 days

• Q0514

  Pharmacy dispensing fee for inhalation drug(s); per 90 days

• Q0516

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-days

• Q0517

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-days

• Q0518

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-days

• Q0519

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-days

• Q0520

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-days

• Q0521

  Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription

• Q2026

  Injection, radiesse, 0.1 ml

• Q2028

  Injection, sculptra, 0.5 mg

• Q2052

  Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)

• Q3014

  Telehealth originating site facility fee

• Q5106

  Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units